A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure
Clinical trial NCT04157751 · COMPLETED
Trial details
- NCT number
- NCT04157751
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2021-05-28
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.